Atlas Trials

Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission

Clinical trial NCT02044952 · UNKNOWN

Trial details

NCT number
NCT02044952
Sponsor
Zhu Weiming
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Inflammatory Bowel DiseasesCrohn's DiseaseGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases
Start date
2014-01-01
Primary completion
2016-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.